pharmaphorum
JULY 12, 2016
Sanofi Pasteur MSD is transforming its commercial organisation and remodeling its approach to customer engagement. Hear from Sanofi Pasteur MSD’s Alexandre Gultzgoff, Deputy Director, IT, and Antoine Blanc, Commercial Excellence Director, as they share first hand insights on how they are transforming their European commercial operations and improving customer engagement.
The Digital Apothecary
JULY 10, 2016
The Premise It comes as no surprise that with all the hype surrounding the use of technology to transform healthcare, that companies (startups & Pharma) are looking to transform traditional medication use. As a pharmacist, this is perhaps the biggest interest I have in the Digital Health sphere, as I feel it may have the largest impact on my profession, and role as an educator.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Med Ed 101
JULY 31, 2016
In ways I admire people who have no trouble carrying debt, because I despise being in debt. Unfortunately it took me about 6 or 7 years of undergrad and pharmacy school to figure that out, and in that time frame I accumulated nearly 145,000 dollars in debt. Pharmacy student loans have felt like a black cloud in […]. The post How to Pay Off 145K in Pharmacy Student Loans appeared first on Med Ed 101.
Med Ed 101
JULY 27, 2016
Converting one medication to another should be done cautiously. We also must recognize that a transition, or equivalent dose is virtually never going to be perfect. So how do you convert levothyroxine to disiccated thyroid? Armour Thyroid is probably the most common disiccated product that I have seen used. The most common dose of Armour […].
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Med Ed 101
JULY 24, 2016
A 72 year old male has a past medical history of CHF, hypertension, hyperlipidemia, GERD, and osteoarthritis. He has had complaints of non-specific leg weakness. He does also report that it is painful at times and does keep him awake occasionally. When questioned, he thinks that maybe his arms are slightly weaker as well. Current […]. The post Non-Specific Leg Weakness – Medication Induced?
pharmaphorum
JULY 21, 2016
New measures proposed by the Government will impact community pharmacies across the UK; the biggest change of this nature in decades. The impact will go beyond community pharmacies as other stakeholders also feel the pressure. UK pharmacies already support more inhabitants per pharmacy than other major European markets; how will this funding change impact how patients are cared for in the community?
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Med Ed 101
JULY 17, 2016
The clock is ticking…the ONE TIME, 50% off deal on the Medication Recommendation Webinar will end at midnight tonight (7/17/2016)! Use discount code: “deal” at checkout. Today’s Education: I’m more on the ambulatory side of pharmacy, but often see big mistakes when it comes to determining how long we should do GI prophylaxis.
pharmaphorum
JULY 14, 2016
The pharmaceutical industry is one of the largest contributing industries to the UK’s balance of trade, and the UK Nation Health Service (NHS) is the fifth largest employer in the world. Although the process of exit for the UK from the EU has now to be triggered by invoking article 50, the post-Brexit calendar is a firestorm of uncertainty. The uncertainty could potentially have a chilling effect on global pharma investment in the UK, but are the issues that will impact Pharma - a jewel in the c
Med Ed 101
JULY 10, 2016
Selection of antipsychotics is challenging, and in my experience, you never know for sure which medication will work for each patient. Here’s a few important clinical pearls regarding the use of antipsychotics. Typical (1st generation) antipsychotics are generally avoided due to a high incidence of troublesome extrapyramidal side effects (EPS). Haloperidol is the classic example […].
Med Ed 101
JULY 6, 2016
Hopefully with this scenario, I’m going to teach you how half-life may affect antidepressant selection. Adherence to antidepressant therapy is a huge issue for our patients. It is often very challenging in the early stages of treatment to convince patients to continue to take their antidepressant because there usually isn’t an immediate effect.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 5, 2016
This webinar will delve into the challenges that pharma face when looking at their patient-centricity strategy, and the opportunities that exist with this approach. We will explore the key motivators for this approach, and steps to overcome the internal and external barriers, and most importantly – how do pharma companies know when they have become truly patient-centric?
Med Ed 101
JULY 3, 2016
I always had this weird feeling in pharmacy school about loperamide (Imodium). I remember learning about it when we were taught about opioids. At the time, I couldn’t help but think why isn’t this a controlled substance if it has opioid activity? I’m sure I learned at some point that the rate entry of loperamide […]. The post Is Loperamide the Next Drug of Abuse?
Expert insights. Personalized for you.
52 
Let's personalize your content